TCL Archive On Capitol Hill: HCFA Closes Comment Period On Proposal For prospective Payment System That Cancer Groups oppose September 17, 1999
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million June 21, 1974
